| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.33 | 0.01 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.24 | 6e-09 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.23 | 1e-06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0008 |